Overview

Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant

Status:
Not yet recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a study to help understand how well new combinations of immunosuppressive medications (medications that weaken your immune system to prevent your body from rejecting the transplanted liver) work compared to standard immunosuppressive medications after your liver transplant. Also the study will assess how safe the new combination of immunosuppressive medicines are and if there are any changes in how your kidneys work after taking these medicines.
Phase:
Phase 4
Details
Lead Sponsor:
Fady M Kaldas, M.D., F.A.C.S.
Treatments:
Basiliximab
Everolimus
Mycophenolic Acid
Sirolimus
Tacrolimus